Rein Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | – | – | – | – | -98.4% | |
| – | – | – | – | – | – | |
| – | +52.3% | +5.6% | -77.8% | +356,903.3% | -22.6% | |
| – | +2.9% | +0.9% | +17.3% | +121,974.5% | -21.4% | |
| – | +29.8% | +3.9% | -41.1% | +399,949.2% | -66.3% | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.